On September 21, 2023, LivaNova PLC reported that Marco Dolci, President of the Company?s Cardiopulmonary Business Unit, announced his intent to retire formally from the Company on December 31, 2023 (Retirement Date). Prior to the Retirement Date, it is expected that Mr. Dolci will continue in his role as President, Cardiopulmonary, and will focus on supporting the transition of his responsibilities. Mr. Dolci joined the Company in March 2017 and has served in his current position since February 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.43 USD | -1.89% |
|
-1.98% | -0.60% |
Jun. 13 | Daniel Jeffrey Moore Resigns as Director of LivaNova PLC | CI |
Jun. 11 | Transcript : LivaNova PLC - Shareholder/Analyst Call |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.60% | 2.79B | |
-5.31% | 181B | |
-5.38% | 99.95B | |
-6.04% | 66.21B | |
+16.45% | 45.4B | |
-8.08% | 45.36B | |
+8.38% | 43.84B | |
+12.06% | 29.03B | |
+17.98% | 25.64B | |
-8.28% | 23.53B |
- Stock Market
- Equities
- LIVN Stock
- News LivaNova PLC
- Marco Dolci to Retire as President of Cardiopulmonary Business Unit of LivaNova PLC on December 31, 2023